Fundraising FoxScilex Pharmaceuticals
Malvern, US · Founded 2012 · Delaware corporation
Find your way into Scilex Pharmaceuticals
Sign up to see every warm intro you have to Scilex Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Scilex Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Scilex Pharmaceuticals was founded in 2012 by Anthony P. Mack.
AP
Anthony P. MackFounder
RC
Richard CohenExecutive
WP
William PedrantiNamed on SEC filing
Board
JB
Jerrold B. SendrowBoard director
EF
Eric FloydBoard director
Reported raises · per SEC filings
Form D private placements$7.5M disclosed across 3 of 4 rounds · 2014–2016
▶$479.9KraisedMay 2016 · 9 investors · PharmaceuticalsRule 506(b)
▶$479.9KraisedMay 2016 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jerrold SendrowDirector
- William PedrantiExecutive Officer, Director
- Anthony MackExecutive Officer, Director
- Eric FloydDirector
- Offering amount
- $479.9K
- Amount sold
- $479.9K
- Placement agents
- Mid Atlantic Medical Association, LLC
- First sale
- May 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$2MraisedMar 2015 · 3 investors · PharmaceuticalsRule 506(b)
▶$2MraisedMar 2015 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Anthony P. MackExecutive Officer, Director
- Jerrold B. SendrowDirector
- William PedrantiExecutive Officer, Director
- Eric FloydDirector
- Offering amount
- $2M
- Amount sold
- $2M
- Sales commissions
- $288.3K
- Placement agents
- Paulson Investment Company, LLC
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$5MofferedAug 2014 · PharmaceuticalsRule 506(b)
▶$5MofferedAug 2014 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Richard CohenExecutive Officer
- Eric FloydDirector
- Jerrold B. SendrowDirector
- William PedrantiExecutive Officer, Director
- Anthony P. MackExecutive Officer, Director
- Offering amount
- $5M
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$5MraisedAug 2014 · 12 investors · PharmaceuticalsRule 506(b)
▶$5MraisedAug 2014 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Anthony P. MackExecutive Officer, Director
- William PedrantiExecutive Officer, Director
- Eric FloydDirector
- Richard CohenExecutive Officer
- Jerrold B. SendrowDirector
- Offering amount
- $5.3M
- Amount sold
- $5M
- Minimum investment
- $100
- Sales commissions
- $434K
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Scilex Pharmaceuticals?
- Scilex Pharmaceuticals was founded by Anthony P. Mack in 2012.
- How much funding has Scilex Pharmaceuticals raised?
- Scilex Pharmaceuticals has disclosed $7.5M raised across 3 of its 4 known rounds.
- Where is Scilex Pharmaceuticals headquartered?
- Scilex Pharmaceuticals is headquartered in Malvern, US.